<?xml version="1.0" encoding="UTF-8"?>

<Composition xmlns="http://hl7.org/fhir">
  <id value="gravitate-Pedro"/>
  <text>
    <status value="generated"/><div xmlns="http://www.w3.org/1999/xhtml"><b>Id:</b> gravitate-Pedro<br/><b>status:</b> final<br/><b>Type:</b> Patient summary Document<br/><b>Subject:</b> Pedro Gravitate<br/><b>Sections:</b><br/><ul><li><b>Title:</b> Problem List<br/><b>Code:</b> Problem list Reported (11450-4)</li><br/><ul><li><b>Entry:</b> <a href="Condition/pedro-cond-1">HIV</a></li><br/><li><b>Entry:</b> <a href="Condition/pedro-cond-2">Depression</a></li><br/><li><b>Entry:</b> <a href="Condition/pedro-cond-3">IBS</a></li><br/></ul><li><b>Title:</b> Medication Summary<br/><b>Code:</b> Hx of Medication use (10160-0)</li><br/><ul><li><b>Entry:</b> <a href="MedicationStatement/pedro-med-stat-1">Dovato lamivudine and dolutegravir, 300 mg/50 mg</a></li><br/><li><b>Entry:</b> <a href="MedicationStatement/pedro-med-stat-2">Mirtazapine 15 mg</a></li><br/><li><b>Entry:</b> <a href="MedicationStatement/pedro-med-stat-3">Calcium carbonate 500 mg</a></li><br/><li><b>Entry:</b> <a href="MedicationStatement/pedro-med-stat-4">Cinitrapide 1 mg</a></li><br/><li><b>Entry:</b> <a href="MedicationStatement/pedro-med-stat-5">Collagen and magnesium supplements</a></li><br/><li><b>Entry:</b> <a href="MedicationStatement/pedro-med-stat-6">Vitamin C supplements</a></li><br/><li><b>Entry:</b> <a href="MedicationStatement/pedro-med-stat-7">Protein supplements</a></li><br/></ul></ul></div>
  </text>
  <status value="final"/>
  <type>
    <coding>
      <system value="http://loinc.org"/>
      <code value="60591-5"/>
      <display value="Patient summary Document"/>
    </coding>
  </type>
  <subject>
    <reference value="Patient/pedro-patient"/>
    <display value="Pedro Gravitate"/>
  </subject>
  <date value="2018-07-10T15:22:00+02:00"/>
  <author>
    <reference value="Practitioner/pedro-pract"/>
    <display value="Dr. Anna Karlsson"/>
  </author>
  <title value="Patient Summary (Pedro Gravitate)"/>
  <confidentiality value="N"/>
  <section>
    <title value="Problem List"/>
    <code>
      <coding>
        <system value="http://loinc.org"/>
        <code value="11450-4"/>
        <display value="Problem list Reported"/>
      </coding>
    </code>
    <entry>
      <reference value="Condition/pedro-cond-1"/>
      <display value="HIV"/>
    </entry>
    <entry>
      <reference value="Condition/pedro-cond-2"/>
      <display value="Depression"/>
    </entry>
    <entry>
      <reference value="Condition/pedro-cond-3"/>
      <display value="IBS"/>
    </entry>
  </section>
  <section>
    <title value="Medication Summary"/>
    <code>
      <coding>
        <system value="http://loinc.org"/>
        <code value="10160-0"/>
        <display value="Hx of Medication use"/>
      </coding>
    </code>
    <entry>
      <reference value="MedicationStatement/pedro-med-stat-1"/>
      <display value="Dovato lamivudine and dolutegravir, 300 mg/50 mg"/>
    </entry>
    <entry>
      <reference value="MedicationStatement/pedro-med-stat-2"/>
      <display value="Mirtazapine 15 mg"/>
    </entry>
    <entry>
      <reference value="MedicationStatement/pedro-med-stat-3"/>
      <display value="Calcium carbonate 500 mg"/>
    </entry>
    <entry>
      <reference value="MedicationStatement/pedro-med-stat-4"/>
      <display value="Cinitrapide 1 mg"/>
    </entry>
    <entry>
      <reference value="MedicationStatement/pedro-med-stat-5"/>
      <display value="Collagen and magnesium supplements"/>
    </entry>
    <entry>
      <reference value="MedicationStatement/pedro-med-stat-6"/>
      <display value="Vitamin C supplements"/>
    </entry>
    <entry>
      <reference value="MedicationStatement/pedro-med-stat-7"/>
      <display value="Protein supplements"/>
    </entry>
  </section>
</Composition>